HARRIS M S
Calif Med. 1951 Aug;75(2):85-8.
Twenty patients with intractable asthma were treated with cortisone on various dosage schedules. Results indicated that a rapid improvement in the asthmatic state may be expected in four to five days with high level dosage of the hormone-usually a total dose exceeding 200 mg. per day at the beginning. If treatment is discontinued after a week, relapse usually will occur within a period of eight days. If small doses are given two or three times weekly, following initial response, relapse may not occur for 20 or 30 days. The interspersed administration of ACTH during an attempt to discontinue cortisone apparently was of no value. It therefore appears that cortisone control of intractable asthma is dependent on large dosage until clinical improvement is obtained, then approximately 100 mg. two or three times a week for maintenance of a reasonable state of health.
20例顽固性哮喘患者接受了不同剂量方案的可的松治疗。结果表明,使用大剂量激素(通常开始时每天总剂量超过200毫克),哮喘状态有望在4至5天内迅速改善。如果一周后停止治疗,通常会在8天内复发。如果在初始反应后每周给予两三次小剂量,可能20或30天内不会复发。在试图停用可的松期间穿插使用促肾上腺皮质激素显然没有效果。因此,看来可的松控制顽固性哮喘依赖于大剂量,直到临床症状改善,然后每周两三次给予约100毫克以维持合理的健康状态。